Start from the main consent requirements

The later consent discussion still needs the full information covered in the Slovakia patient information and consent guide. Do not replace the standard Participant Information Sheet and Informed Consent Form with a one-page emergency notice.

Emergency enrollment is a protocol-specific variation. The protocol and Part II documents must identify the exact emergency condition and intervention window. A site-level convenience procedure is not enough.

Conditions that must all be met

Conditional. Article 35 applies only when:

  • the participant faces a sudden life-threatening or other sudden serious medical condition
  • the participant cannot provide prior informed consent and cannot receive prior information
  • it is impossible within the therapeutic window to obtain prior consent from a legally designated representative
  • no earlier objection to trial participation is known
  • the research relates directly to the medical condition causing the impossibility of consent
  • the trial cannot be carried out effectively outside emergency situations
  • participation has the prospect of direct clinically relevant benefit that may produce a measurable health improvement or prevent serious suffering
  • the risk and burden are minimal in comparison with standard treatment for the condition

Explain each condition in the application. Do not state only that the trial follows Article 35.

Required patient-facing and procedural documents

Prepare:

  • a full Slovak Participant Information Sheet and Informed Consent Form for the participant once capable
  • a full Slovak legal-representative information and consent form for use while the participant remains unable to consent
  • a short initial information notice if it can be provided without delaying urgent care
  • a procedure describing eligibility confirmation, representative searches, enrollment authorization, documentation and later consent
  • a refusal and withdrawal process covering intervention, follow-up, data and samples

The blank documents are submitted in Part II. The later consent forms are signed and personally dated by the participant or legal representative and the person conducting the discussion.

Initial enrollment documentation

Define who confirms that Article 35 conditions are met and what is recorded in the source file. The record should show the emergency facts, the therapeutic window, why the participant could not consent, why a representative could not be reached in time, checks for prior objection and the enrollment decision.

The protocol should state whether an independent physician or other safeguard is involved. Do not invent a national waiver form where no verified Slovak template exists.

Subsequent information and consent

Provide information and seek consent without undue delay once the participant can decide or a legal representative becomes available. Explain what has already happened, current risks, remaining procedures and the right to refuse continued participation.

If the representative consents and the participant later regains capacity, obtain the participant's own consent. If the participant or representative refuses, stop trial-specific procedures unless immediate safety care is needed. Explain the handling of data already obtained and samples already analyzed without promising deletion that would conflict with the Clinical Trials Regulation.

Slovakia-specific points

The participant-use documents must be in Slovak. The national Ethics Committee assesses the Part II justification and consent pathway. Slovakia does not publish a separate verified national emergency-consent template in the sources used for this guide, so use the EU legal conditions and adapt the ordinary Slovak consent documents.

Slovak law prohibits enrollment of people in custody, serving a prison sentence or held in detention. Emergency circumstances do not remove that national exclusion.

Submission checks

Confirm that the protocol, recruitment and consent procedure, forms and site workflow agree on the emergency condition, therapeutic window, representative search, prior-objection check, enrollment authorization, later consent and refusal handling.

Check that every Slovak site has staff and facilities capable of applying the pathway without delaying emergency care. Use the Slovakia Part II document checklist for the site and insurance evidence and the patient-facing QC checklist for the final documents.

Return to the Slovakia CTIS hub for the complete country series.

Prepare the emergency pathway in minutes

TrialAgents can generate the full Slovakia-specific emergency enrollment package in minutes, saving weeks of manual drafting and document alignment.

Official sources and resources

  1. Regulation (EU) No 536/2014, Article 35 on clinical trials in emergency situations
  2. Slovak Act No. 362/2011 Coll., sections 29a(7) to 29a(9)
  3. State Institute for Drug Control, Good Clinical Practice for investigators, section 4.8
  4. European Commission, EudraLex Volume 10 clinical trial guidelines
  5. European Commission, Questions and Answers on the Clinical Trials Regulation, March 2026

Last reviewed: 31 August 2026